Barbara Kraus

Title: The Innovative Contributions of Barbara Kraus

Introduction

Barbara Kraus is a notable inventor based in Obersdorf, Austria. She has made significant contributions to the field of biotechnology, particularly in the area of adeno-associated virus (AAV) purification methods. With a total of five patents to her name, her work has had a substantial impact on the development of viral vector technologies.

Latest Patents

Among her latest patents, Barbara Kraus has developed methods for producing an adeno-associated virus (AAV) product. These methods include techniques for purifying adeno-associated virus and for isolating full AAV capsids from a concentrated AAV fraction that contains both empty and full AAV capsids. This innovative approach enhances the efficiency and effectiveness of AAV production, which is crucial for gene therapy applications.

Career Highlights

Throughout her career, Barbara has worked with prominent companies in the biotechnology sector, including Baxter International Inc. and Baxter Healthcare SA. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking advancements in her field.

Collaborations

Barbara has collaborated with esteemed colleagues such as Leopold Grillberger and Manfred Reiter. These partnerships have fostered a collaborative environment that has led to the successful development of her patented technologies.

Conclusion

Barbara Kraus exemplifies the spirit of innovation in biotechnology through her significant contributions and patents. Her work continues to influence the field and pave the way for future advancements in gene therapy.